J&J on the move, new Antibiotic approved

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Okay ertapenem doesn't cover pseudomonas... imipenem and meropenem.
 
I'm so sad...I try to edumacate you young folks..and some old farts.. and newbies come on board and think I'm loud mouthed.. wait, they're right.. :meanie:
 
It says it has activity against c. diff....but wouldn't you be worried about it causing c. diff since it is so broad spectrum?
 
It says it has activity against c. diff....but wouldn't you be worried about it causing c. diff since it is so broad spectrum?

You asking me?

Why don't you tell me...
 
I am actually not sure....that is what I would think. You are killing off a lot of that gut bacteria.
 
I am actually not sure....that is what I would think.

C.Diff...that would be a good topic for you to delve into...
 
It's just another rambling clinical thread 🙄.
 
I am actually not sure....that is what I would think. You are killing off a lot of that gut bacteria.

but we already have with ertabpenm, imipenem, and meropenem...
 
C.Diff...that would be a good topic for you to delve into...

I know all about C. Diff...I could smell it a mile away. Everyone at the VA had it. Not good.
 
I know all about C. Diff...I could smell it a mile away. Everyone at the VA had it. Not good.

Oh is that right.... so what's caused all those C.Diff outbreak recently
 
Dirty hands

:meanie::meanie: You're scrambling.. yes, dirty hands had a lot to do with it... gather your thoughts and organize it..
 
:meanie::meanie: You're scrambling.. yes, dirty hands had a lot to do with it... gather your thoughts and organize it..

I thought I finished my rotations....

C. Diff has spores that are stable on surfaces...which is why proper contact precautions and disinfection of the patient room are necessary.
 
This article is too large for me to load here..

If you have a subscription to CID...then more better... but here is a good read.

Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium ...
Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; et al
Clinical Infectious Diseases; Nov 1, 2005; 41, 9; Research Library
 
how can we believe that? And how does that translate to clinical outcomes?

It's a carbapenem...broadest spectrum spectrum beta-lactams...good DOC for gram-neg when resistance is an issue. If it really is more potent than Meropenem, we're probably talking MIC's of 4 rather than 8+. Seems like it's main place will be with serious nosocomial infections where resistance is an issue.
 
It's a carbapenem...broadest spectrum spectrum beta-lactams...good DOC for gram-neg when resistance is an issue. If it really is more potent than Meropenem, we're probably talking MIC's of 4 rather than 8+. Seems like it's main place will be with serious nosocomial infections where resistance is an issue.

Why not keep using Imipenem or Meropenem
 
Depends...are there issues with resistance in this imaginary hospital?

I haven't come across too many hospitals with Carbapenem resistance issues... I know one in CT who's having issues..
 
Learning is different from being harassed by the clinical gods. I'm not scrambling for scraps.

YES! He called me the clinical god!!!! oh ..she.
 
Rather than learn everything about ID, I'm going to invent the antibiotic that kills everything and is impervious to resistance. That seems easier.
 
Sorry...work called me and told me I didn't have to come in today...so I went back to bed.... Where were we?
 
Sorry...work called me and told me I didn't have to come in today...so I went back to bed.... Where were we?

"we" are getting ready for a conference call...
 
Top